TOPIC - Clinical trials: The American story
Clinical trials are a hot topic; consider the controversy around the COVID-19 studies. Rules and regulations governing clinical trials have evolved over time, primarily driven by ethical considerations and the need for scientific rigor. We will explore some famous examples of ethical violations in US clinical trials that have shaped these regulations, which fortunately have led to checks and balances.
In addition, we will examine diversity in US clinical trials which is essential to ensure that the safety and efficacy of medical treatments can be generalized to all populations. Particularly analyzing diversity in the COVID-19 clinical trials.
Finally, this presentation will focus on the reluctance of some groups to participate in clinical trials, which is a complex issue with various factors contributing to this hesitancy.
SPEAKER: James Muhitch, Manager of Clinical Scientists, Galderma Research
Dr. James Muhitch is a manager of clinical scientists at Galderma Research & Development in Dallas, TX. In this role, Dr. Muhitch leads a very talented and passionate team with a deep commitment to advancing the field of dermatology through clinical research and innovation. He is a scientific leader with extensive experience spanning pharmaceuticals, medical devices, and consumer products at top Fortune 500 companies such as Johnson & Johnson, Novartis, and Nestle.
James holds a PhD in Chemical Engineering and Master of Science in Molecular and Cellular Biology from Tulane University. In addition, he holds MS and BS degrees in chemical engineering and a BA in chemistry from the University of Buffalo.
- Log in to post comments